Training new scientists in rheumatic diseases
Official title: Training Program/Rheumatic Diseases
Funded at University of Pennsylvania · NIH-11094963 · Data updated 2026-11-12
This program is training new scientists to explore the causes and treatments of rheumatic diseases, like arthritis, by working together at the University of Pennsylvania and the Children’s Hospital of Philadelphia, so they can help improve care for patients of all ages.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | May 1, 2020 |
| Project end | May 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $343,814 |
| NIH project number | 2T32AR076951-06 |
| Project ID | NIH-11094963 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals with rheumatic diseases or musculoskeletal pain disorders.
✕Less likely to help
Patients with non-rheumatic conditions or those not affected by musculoskeletal pain disorders may not receive benefit from this research.
What this research studies
This program focuses on training new scientists to investigate the causes, diagnosis, treatment, and outcomes of rheumatic diseases. It combines efforts from both adult and pediatric rheumatology divisions at the University of Pennsylvania and the Children’s Hospital of Philadelphia. Participants will engage in a variety of research methodologies, including laboratory investigation, clinical epidemiology, and bioinformatics, to advance understanding and treatment of musculoskeletal pain disorders. The program aims to develop future leaders in the field of rheumatology through a collaborative and multidisciplinary approach.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and outcomes for patients suffering from rheumatic diseases.
How similar studies have gone: Other training programs in rheumatology have shown success in developing new treatments and improving patient care, indicating a strong potential for this program as well.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Merkel, Peter a — University of Pennsylvania
- Study coordinator: Merkel, Peter a
Related research
Other NIH-funded projects on the same topics.
-
Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups with Rheumatic Diseases
A patient-facing program tests a multi-modal approach using storytelling videos and trained patient navigators to help Black and Latinx adults with autoimmune rheumatic diseases get recommended COVID-19 vaccines and boosters.
-
How health policies affect people with systemic autoimmune and rheumatic conditions
This project looks at how health policies and medical care affect health and pregnancy outcomes for reproductive-age women with systemic autoimmune and rheumatic diseases.
-
Long-term immune and health effects of COVID-19 in people with autoimmune rheumatic diseases
This project looks at how COVID-19 changes immune responses and causes lingering symptoms in people with autoimmune rheumatic diseases like rheumatoid arthritis and lupus.
-
How health policies impact women with autoimmune diseases during pregnancy
This study is looking at how health policies affect women with autoimmune and rheumatic diseases during pregnancy, aiming to understand their experiences and access to care, so we can better support their health and treatment options.
-
Helping Black and Latinx patients with rheumatic diseases get recommended COVID-19 vaccines
This project helps Black and Latinx adults living with autoimmune rheumatic diseases get their recommended COVID-19 vaccines.
-
Effects of COVID-19 on patients with autoimmune diseases
This study is looking at how COVID-19 affects people with autoimmune diseases like rheumatoid arthritis and lupus, to better understand their immune responses and how their treatments might change their reactions to the virus and vaccines, ultimately aiming to improve their health outcomes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.